Abstract:Aim: To investigate the effect of Mu-opioid receptor(MOR) agonist remifentanil-poly-caprolactone(REM-PCL) on the somatosensory evoked potential(SEP) of rabbits with spinal cord ischemia reperfusion injury(SCIRI). Meth-ods: A total of 30 healthy rabbits were randomly allocated into control group, R group and RG group, 10 rabbits in each group. In group R and RG, the infrarenal abdominal aorta occlusion method was used to establish SCIRI model, and then REM-PCL was perfused at 0. 1 mg/ kg by abdominal aorta; RG group were given local perfusion of MOR antagonist GSK1521498(1 mg/ kg), and the rabbits in the control group were perfused with normal saline. Before occlusion, after reperfusion for 15, 30, 60 min and reperfusion for 24 h, the serum neuron specific enolase(NSE) concentration and SEP were monitored; after reperfusion for 6, 12 and 24 h, neurobehavioral score was assessed and MOR mRNA and sensory neurons abnormal rate in spinal cord tissue were detected. Results: The differences in serum NSE level, SEP changes, neurobehavioral score, MOR mRNA expression and sensory neurons abnormal rate among the 3 groups were statistically sig-nificant(P < 0. 05). The indexes mentioned above and the change trend of RG group were similar to those of the control group(P > 0. 05). Compared with the control group and RG group, during reperfusion, OL showed a lesser extent, IPA re-covered rapidly, the concentration of serum NSE and neurobehavioral scores were lower in R group;after reperfusion for 24 h, MOR mRNA expression in spinal cord tissue were higher, and sensory neuron abnormal rate was significantly lower(P <0. 05). Conclusion: REM-PCL perfusion in abdominal aorta could relieve spinal cord electrophysiological dysfunction by activating MOR.

Effect of REM-PCL on somatosensory-evoked potential of rabbits with spinal cord ischemia reperfusion injury